Approvals/CIMA-AEMPS/RISPERIDONA TEVA 37,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG

Approved

STANDARD

RISPERIDONA TEVA 37,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG

Teva Pharma S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 263eb3818bb0f229
Drug Cima Aemps Name: RISPERIDONA TEVA 37,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Register Number: 85707
Holder Company Name: Teva Pharma S.L.U.
Marketing Company Name: Teva Pharma S.L.U.
Authorization Date: 2021-01-20
Dosage Form: POLVO Y DISOLVENTE PARA SUSPENSIÓN INYECTABLE DE LIBERACIÓN PROLONGADA
Dose: 37,5 mg
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva Pharma S.L.U.

RISPERIDONA

37,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 20, 2021

Approval ID

263eb3818bb0f229

Type

Standard